Levere Holdings $250 million IPO
We advised the underwriters on the SPAC IPO and Nasdaq listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Anglo American $1 billion notes offering
We advised the underwriters on the Rule 144A senior notes offering
Oncopeptides SEK 1.1 billion private placing of new shares
We advised Oncopeptides on the private placement of shares
Deutsche Bank $1.25 billion subordinated Tier 2 notes offering
We advised the underwriters in connection with the SEC-registered offering
Xspray Pharma SEK 265 million private placing of new shares
Davis Polk advised Xspray Pharma AB (publ) on a private placing of new shares. The private placing raised gross proceeds of approximately SEK 265 million.
Xspray was founded in 2003 as a…
Smith+Nephew $1 billion notes offering
Davis Polk advised Smith & Nephew plc in connection with the establishment of a WKSI shelf and its debut SEC-registered shelf takedown of $1 billion aggregate principal amount of 2.032%…
NatWest Group cash tender offer
Davis Polk advised NatWest Group plc in connection with its cash tender offer for any and all of certain series of its outstanding bank capital securities.
NatWest Group is the holding…
Centogene $49 million follow-on offering
Davis Polk advised Centogene N.V. on its $49 million follow-on public offering of 3,500,000 of its common shares, consisting of 2,000,000 common shares offered by Centogene and 1,500,000…
British American Tobacco $2.4 billion notes offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of $900 million aggregate principal amount of 4.700% notes due 2027, $1…
SEAS-NVE DKK 6.1 billion sale of shares in Ørsted
Davis Polk advised SEAS-NVE A.m.b.A. in connection with the unregistered sale of 9,532,013 shares of common stock in Ørsted A/S, representing 2.27% of Ørsted’s share capital, by way of an…